BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17476281)

  • 1. Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies.
    Guillem VM; Collado M; Terol MJ; Calasanz MJ; Esteve J; Gonzalez M; Sanzo C; Nomdedeu J; Bolufer P; Lluch A; Tormo M
    Leukemia; 2007 Jul; 21(7):1413-22. PubMed ID: 17476281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
    Haase D; Hanf V; Schulz T
    Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in DNA repair and metabolic genes in bladder cancer.
    Sanyal S; Festa F; Sakano S; Zhang Z; Steineck G; Norming U; Wijkström H; Larsson P; Kumar R; Hemminki K
    Carcinogenesis; 2004 May; 25(5):729-34. PubMed ID: 14688016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from the Czech Republic.
    Pardini B; Kumar R; Naccarati A; Prasad RB; Forsti A; Polakova V; Vodickova L; Novotny J; Hemminki K; Vodicka P
    Mutat Res; 2011 Mar; 721(1):74-80. PubMed ID: 21211571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemia.
    Nückel H; Frey UH; Dürig J; Dührsen U; Siffert W
    Leukemia; 2004 Nov; 18(11):1816-23. PubMed ID: 15385937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation.
    Terrazzino S; Agostini M; Pucciarelli S; Pasetto LM; Friso ML; Ambrosi A; Lisi V; Leon A; Lise M; Nitti D
    Pharmacogenet Genomics; 2006 Nov; 16(11):817-24. PubMed ID: 17047490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
    Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
    J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies.
    Kim HN; Kim YK; Lee IK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Park MR; Jo DY; Won JH; Kwak JY; Kim HJ
    Leuk Res; 2009 Jan; 33(1):82-7. PubMed ID: 18774170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of secondary leukemias.
    Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
    Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTHFR 677C-->T and 1298A-->C polymorphisms in children with Down syndrome and acute myeloid leukemia in Brazil.
    Amorim MR; Zanrosso CW; Magalhães IQ; Pereira SC; Figueiredo A; Emerenciano M; Pinheiro VR; d'Andréa ML; Orioli IM; Koifman S; Pombo-de-Oliveira MS
    Pediatr Hematol Oncol; 2008 Dec; 25(8):744-50. PubMed ID: 19065440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between methylenetetrahydrofolate reductase genetic polymorphisms and postmenopausal breast cancer risk.
    Ziva Cerne J; Stegel V; Gersak K; Novakovic S
    Mol Med Rep; 2011; 4(1):175-9. PubMed ID: 21461582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study.
    Karagas MR; Park S; Nelson HH; Andrew AS; Mott L; Schned A; Kelsey KT
    Int J Hyg Environ Health; 2005; 208(5):321-7. PubMed ID: 16217917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylenetetrahydrofolate reductase gene polymorphisms and risk of acute lymphoblastic leukemia in children.
    Sadananda Adiga MN; Chandy S; Ramachandra N; Appaji L; Aruna Kumari BS; Ramaswamy G; Savithri HS; Krishnamoorthy L
    Indian J Cancer; 2010; 47(1):40-5. PubMed ID: 20071789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and susceptibility to therapy-related myeloid neoplasms.
    Leone G; Fianchi L; Pagano L; Voso MT
    Chem Biol Interact; 2010 Mar; 184(1-2):39-45. PubMed ID: 20026017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
    Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
    Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population.
    Schnakenberg E; Mehles A; Cario G; Rehe K; Seidemann K; Schlegelberger B; Elsner HA; Welte KH; Schrappe M; Stanulla M
    BMC Med Genet; 2005 May; 6():23. PubMed ID: 15921520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia.
    Bolufer P; Collado M; Barragan E; Calasanz MJ; Colomer D; Tormo M; González M; Brunet S; Batlle M; Cervera J; Sanz MA
    Br J Haematol; 2007 Feb; 136(4):590-6. PubMed ID: 17367411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of DNA damage and repair upon the risk of treatment related leukemia.
    Guillem V; Tormo M
    Leuk Lymphoma; 2008 Feb; 49(2):204-17. PubMed ID: 18231906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study.
    Lin J; Spitz MR; Wang Y; Schabath MB; Gorlov IP; Hernandez LM; Pillow PC; Grossman HB; Wu X
    Carcinogenesis; 2004 Sep; 25(9):1639-47. PubMed ID: 15117811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylenetetrahydrofolate reductase gene polymorphisms c.677C/T and c.1298A/C are not associated with open angle glaucoma.
    Mabuchi F; Tang S; Kashiwagi K; Yamagata Z; Iijima H; Tsukahara S
    Mol Vis; 2006 Jul; 12():735-9. PubMed ID: 16862068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.